Journal of Diabetes Research · 2015 · 15 citations · 39 references
MedicineEndocrinologyImmunologyDiabetologyGlycobiologyInflammationCardiovascular DiseaseDiabetes MellitusAtherosclerosis RiskComplement System ActivationComplement System DysfunctionDiabetes Mellitus PathophysiologyMannose-binding LectinsMultiple RegressionSubclinical AtherosclerosisType 2 Diabetes Pathophysiology
INTRODUCTION: Mannose-binding lectin (MBL) activates complement system and has been suggested to play a role in vascular complications in diabetics. Carotid intima-media thickness (cIMT) detects subclinical atherosclerosis. We evaluated the association of MBL and IMT in type 2 diabetic (T2DM) patients. METHODS: Serum MBL levels and cIMT were measured in a total of 103 diabetics and in 98 age-matched healthy controls. RESULTS: There was no significant difference in MBL level in T2DM versus controls. As expected, IMT was significantly higher in T2DM patients than in controls (P = 0.001). In T2DM, the lowest cIMT was seen in patients with normal MBL level (500-1000) while cIMT continuously increased with both high MBL and absolute MBL deficiency states. This was especially significant in high MBL versus normal MBL T2DM patients (P = 0.002). According to multiple regression analysis the main predictors of IMT in T2DM are age (P < 0.003), ApoA level (P = 0.023), and the MBL (P = 0.036). CONCLUSIONS: Our results suggest a dual role of MBL as a risk factor for cIMT in T2DM. MBL may also be used as a marker of macrovascular disease, as both low and high levels indicate the susceptibility for atherosclerosis in T2DM.
39
Carol Anne Ogden, Aimee M. deCathelineau, Peter Hoffmann et al. · The Journal of Experimental Medicine · 2001 · 1.1K citations · Full text
Brian J. Van Lenten, Susan Hama, Frederick C. de Beer et al. · Journal of Clinical Investigation · 1995 · 832 citations · Full text